Eikon Therapeutics, Inc. Common Stock (EIKN) vs Fennec Pharmaceuticals Inc. (FENC)
A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and Fennec Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EIKN
Eikon Therapeutics, Inc. Common Stock
$7.66HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
FENC
Fennec Pharmaceuticals Inc.
$10.25HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — EIKN vs FENC
growth of $100 · dividends reinvested · last 1yEIKN -49.7% (-49.7%/yr)FENC +34.3% (+34.3%/yr)FENC compounded faster over this window
EIKN FENC
EIKN vs FENC: by the numbers
- •EIKN is the larger company ($415M vs $356M market cap).
- •Both run net losses; EIKN's is the smaller (0.00% vs -5.49% net margin).
Metrics side by side
Valuation
| Metric | EIKN | FENC |
|---|---|---|
| Forward P/E | N/A | 36.18 |
| P/S ratio | N/A | 6.01 |
| P/B ratio | 0.89 | 8.39 |
Profitability
| Metric | EIKN | FENC |
|---|---|---|
| Gross margin | 0.00% | 93.73% |
| Operating margin | 0.00% | -14.22% |
| Net margin | 0.00% | -5.49% |
| ROE | -69.06% | -7.66% |
| ROIC | -46.16% | -1.84% |
Growth (annualized)
| Metric | EIKN | FENC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 222.46% |
| Total return CAGR (5Y) | N/A | 2.45% |
Go deeper
Dig into the metrics
Eikon Therapeutics, Inc. Common Stock ROEFennec Pharmaceuticals ROEEikon Therapeutics, Inc. Common Stock operating marginFennec Pharmaceuticals operating marginEikon Therapeutics, Inc. Common Stock revenue growthFennec Pharmaceuticals revenue growthEikon Therapeutics, Inc. Common Stock free cash flowFennec Pharmaceuticals free cash flow
Eikon Therapeutics, Inc. Common Stock & Fennec Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.